vincristine-induced neuropathy
Related entities
Findings (50)
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementChildren in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit
Effect: improvement; 8.42 points higher on PedsQL total score
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement
None
improvementGlutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
Effect: improvement